Mablytics Inc

Mablytics Inc is a preclinical stage biotechnology company based in San Diego, CA. They are focused on developing precision-guided immunotherapies using fully human monoclonal antibodies directed at a novel target. Their innovative approach aims to provide more effective and safer therapy delivery for certain oncological diseases, offering hope for patients diagnosed with difficult-to-treat cancers worldwide.

With a deep understanding of a cell-surface protein and enhanced knowledge about its unique expression, Mablytics is paving the way for a new generation of immunotherapies. Their research has shown highly restricted expression of the novel target in normal tissues but overexpression in certain cancers, making immunotherapies directed at this target potentially highly effective with low toxicity. By selectively delivering targeted therapies to tumor cells across multiple cancer types, Mablytics aims to minimize the impact on noncancerous cells and improve the lives of patients.

Generated from the website